Cite
HARVARD Citation
Flint, A. et al. (2021). Editorial: evolution of GLP‐1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity – authors' reply. Alimentary pharmacology & therapeutics. 54 (11), p. 1498. [Online].